课题基金 / 基金详情

Research for the mechanism of ischemic tolerance in neuronal cells

Research for the mechanism of ischemic tolerance in neuronal cells
神经细胞缺血耐受机制研究
批准号:
13671446
负责人:
YANO Shigetoshi
金额:
$2.5万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

YANO Shigetoshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To investigate the mechanism of ischemic tolerance, we first focused on the activity of Akt that was reported as a key enzyme of anti-apoptotic signaling. Sublethal ischemia gradually and persistently activated Akt in hippocampal CA1 region. Intra-cerebral ventricular infusion of wortmannin prior to preconditioning blocked both the increase in Akt activation and the neuroprotective action of preconditioning. Next we examined the activation of CREB that was one of the candidates for the target of Akt signaling. Phosphorylation and binding activity of CREB after sublethal ischemia was observed transiently. Inhibition of CREB-DNA binding by infusion of CRE-decoy into the cerebral ventricle resulted in failure of induction of ischemic tolerance. These results suggested that Akt signaling and CREB activation contributed to neuroprotective ischemic tolerance in CA1 pyramidal neurons. As these effects could not explain the entire mechanism of ischemic tolerance, we are going to keep on investigating other key molecules.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
Naoki Shinojima: "Myofibroblastoma in the suprasellar region. Case report"Journal of Neurosurgery. 97. 1203-1207 (2002)
Naoki Shinojima:“鞍上区肌纤维母细胞瘤。病例报告”神经外科杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kazunari Koga: "Expression of Angiopoietin-2 in human glioma cells and its role for angiogenesis"Cancer Research. 61. 6248-6254 (2001)
Kazunari Koga:“Angiopoietin-2 在人神经胶质瘤细胞中的表达及其对血管生成的作用”癌症研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tatemi Todaka: "Successful clipping of a distal posterior inferior cerebellar artery aneurysm located on the anterior surface of the medulla oblongata--case report"Neurol Med Chir (Tokyo). 42. 158-161 (2002)
Tatemi Todaka:“成功夹闭位于延髓前表面的小脑后下动脉远端动脉瘤——病例报告”Neurol Med Chir(东京)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takayuki Kawano: "Neuroprotective effect of sodium orthocanadate on delayed neuronal death after transient forebrain ischemia in gerbil hippocampus"J Cerb. Blood Flow Metab. 21. 1268-1280 (2001)
Takayuki Kawano:“原加拿大酸钠对沙鼠海马短暂前脑缺血后迟发性神经元死亡的神经保护作用”J Cerb。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
19
    Mechanism of generation of pituitary adenomas based on theidentification of pituitary tumor stem cells
    • 批准号:
      22659263
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $1.43万
    • 财政年份:
      2010
    • 负责人:
      YANO Shigetoshi
    • 依托单位:
    国内基金
    海外基金
    腺苷通过ADORA1/PI3K/AKT/CREB通路调控巨噬细胞M2极化在银屑病中的作用及机制研究
    • 批准号:
      2025JJ60494
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      徐铭
    • 依托单位:
    湿邪通过肠道特征性代谢物介导PI3K/Akt/CREB通路导致“湿性重浊”抑郁样行为的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      15.0万元
    • 批准年份:
      2024
    • 负责人:
      许华冲
    • 依托单位:
    AKT提高IGF2BP2蛋白稳定性影响m6A修饰的CREB1mRNA促进心肌纤维化的机制研究
    • 批准号:
      82360062
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      32万元
    • 批准年份:
      2023
    • 负责人:
      田承南
    • 依托单位:
    1类创新化药硝酮嗪通过调控AMPK/PGC1α/Nrf2和PI3k/Akt/CREB信号通路促进神经再生治疗缺血性脑卒中的药效和作用机理研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2022
    • 负责人:
      张高小
    • 依托单位: